Drug Type Small molecule drug |
Synonyms Tripelennamine, Tripelennamine hydrochloride (USP), 曲吡那敏 + [4] |
Target |
Action antagonists |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date United States (19 Feb 1948), |
Regulation- |
Molecular FormulaC16H22ClN3 |
InChIKeyFSSICIQKZGUEAE-UHFFFAOYSA-N |
CAS Registry154-69-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02091 | Tripelennamine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Asthma | China | 01 Jan 1995 | |
Dermatitis | China | 01 Jan 1995 | |
Eczema | China | 01 Jan 1995 | |
Rhinitis, Allergic | China | 01 Jan 1995 | |
Rhinitis, Allergic, Seasonal | China | 01 Jan 1995 | |
Urticaria | China | 01 Jan 1995 | |
Common Cold | United States | 19 Feb 1948 | |
Cough | United States | 19 Feb 1948 | |
Hypersensitivity | United States | 19 Feb 1948 |